Leaflet ELYMBUS 0.1mg / g single dose ophthalmic gel


Indicated for: glaucoma; ocular hypertension

Route of administration: ophthalmic

Substance: bimatoprost (glaucoma agent)

ATC: S01EE03 (Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues)

Bimatoprost is a medication used to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It belongs to a class of drugs called prostaglandin analogs, which work by increasing the outflow of fluid from inside the eye, thereby lowering pressure.

The medication is available as eye drops and is typically administered once daily in the evening. It is important for patients to strictly follow their doctor's instructions to prevent vision deterioration.

Common side effects include eye redness, itching, burning sensation, and changes in iris color. In some cases, eyelash growth may occur, which some patients may consider a cosmetic benefit.

Bimatoprost is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other eye conditions or medications being used to avoid drug interactions.

General data about ELYMBUS 0.1mg / g

  • Substance: bimatoprost
  • Date of last drug list: 01-09-2023
  • Commercial code: W69737001
  • Concentration: 0.1mg / g
  • Pharmaceutical form: single dose ophthalmic gel
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: LABORATOIRE UNITHER - FRANTA
  • Holder: LABORATOIRES THEA - FRANTA
  • Number: 15105/2023/01
  • Shelf life: 3 years-after packing for marketing/1 luna-deschiderea plicului/it is used immediately

Pharmaceutical forms available for bimatoprost

Concentrations available for bimatoprost

  • 0.1mg/g
  • 0.1mg/ml
  • 0.3mg/ml

Combinations with other substances